Acute Pancreatitis and Acute Cholecystitis Caused by Hemobilia after Percutaneous Ultrasound-Guided Liver Biopsy

Albuquerque, Werner Rocha; Arantes, Vitor; Farah, Kátia de Paula; Lambertucci, José Roberto

doi:10.1055/s-2005-870407

Cited by 18 publications

(22 citation statements)

References 1 publication

(1 reference statement)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…10 In HD patients, the rate of complications is elevated due to higher risk of bleeding secondary to haemostatic disorders. 11,12 In a recent study, severe complications of liver biopsies were demonstrated in 13.2% of HD patients. 13 Therefore, there is a need to assess the utility of noninvasive markers of fibrosis in this population.…”

Section: Introductionmentioning

confidence: 99%

Hyaluronic acid in the evaluation of liver fibrosis in patients with hepatitis C on haemodialysis

Ávila¹,

Carmo²,

Farah³

et al. 2010

Braz J Infect Dis

View full text Add to dashboard Cite

Background: This study evaluated the role of HA as a marker of liver fi brosis in patients with hepatitis C on haemodialysis. Methods: This is a cross-sectional study in which 52 patients were divided into two groups: Group 1: patients with hepatitis C and end-stage renal disease (ESRD) undergoing haemodialysis (n = 23); and Group 2: patients with hepatitis C without ESRD (n = 29). Plasma levels of HA were associated with histological data of the samples obtained by liver biopsy and classifi ed by METAVIR group scoring system. Results: Higher plasma levels were signifi cantly correlated to signifi cant liver fi brosis (METAVIR ≥ F2). In Group 1, the HA cutoff to discriminate signifi cant fi brosis was 984.8 ng/mL, with accuracy, sensitivity and specifi city of 80.8%, 83.0%, and 70.0%, respectively. In Group 2, the HA cutoff was 222.3 ng/mL, with accuracy, sensitivity and specifi city of 74.5%, 70.0%, and 94.0%, respectively. Conclusion: HA was an accurate noninvasive marker in predicting signifi cant fi brosis in patients with hepatitis C on haemodialysis.

show abstract

Section: Introductionmentioning

confidence: 99%

Hyaluronic acid in the evaluation of liver fibrosis in patients with hepatitis C on haemodialysis

Ávila¹,

Carmo²,

Farah³

et al. 2010

Braz J Infect Dis

View full text Add to dashboard Cite

show abstract

“…In 1999, there were two patients who developed pancreatitis secondary to hemobilia from PLB and were the first ones treated with ERCP and sphincterotomy [Jornod et al 1999;Kim et al 1999]. Since then, there have only been three other cases (including ours) where ERCP has been successful as a diagnostic and therapeutic modality [Albuquerque et al 2005;Nowak et al 2005]. Angiography with embolization is also a tool that has been successful in the treatment of this rare complication; however, its utility is limited to the amount of bleeding, requiring a bleeding rate of at least 0.5 to 1.0 ml/min [Nusbaum and Baum, 1963].…”

Section: Implications For Clinical Carementioning

confidence: 99%

“…The first report of hemobilia causing acute pancreatitis came in 1975 as a complication of a percutaneous transhepatic cholangiogram [Redman and Joseph, 1975]. Since this, there have been ten reported cases described in the literature of acute pancreatitis following PLB and hemobilia [Albuquerque et al 2005;Nowak et al 2005;Machicao et al 2002;Sood et al 2002;Asselah et al 2001;Gomez-Valero et al 2001;Jornod et al 1999;Kim et al 1999;Van Os and Petersen, 1996;De Ribot et al 1995]. In 1999, there were two patients who developed pancreatitis secondary to hemobilia from PLB and were the first ones treated with ERCP and sphincterotomy [Jornod et al 1999;Kim et al 1999].…”

Section: Implications For Clinical Carementioning

confidence: 99%

Acute pancreatitis secondary to hemobilia after percutaneous liver biopsy

Peña

Horn

Cross

2009

Therap Adv Gastroenterol

View full text Add to dashboard Cite

Percutaneous liver biopsy (PLB) is a valuable diagnostic tool. Complication rates vary depending on the technique used, experience of the physician, number of passes, bleeding parameters and other factors. Hemorrhage is a common complication after PLB and can present as intraperitoneal bleeding, intrahepatic or subcapsular hematoma, or rarely as hemobilia. Acute pancreatitis is a rare complication of hemobilia. We describe a single case of acute pancreatitis caused by biliary obstruction due to hemobilia following PLB. The obstruction was successfully managed with biliary stent drainage.

show abstract

“…Endoscopic retrograde cholangiopancreatography (ERCP) is useful for locating and extracting blood clots. Angiography is preferred for the diagnosis and treatment of pseudoaneurysms, arteriobiliary fistulas, and arterioportal fistulas (5,6).…”

Section: Discussionmentioning

confidence: 99%

“…In the literature, only nine acute pancreatitis and eight acute cholecystitis cases have been reported as a complication after hemobilia (3). However, acute cholecystitis and acute pancreatitis secondary to hemobilia have been reported in only two cases (4,5). Primary causes of performing hemobilia-related PLB are pseudoaneurysms on the needle tract and arterioportal fistulas.…”

Section: Introductionmentioning

confidence: 99%

Acute Cholecystitis and Acute Pancreatitis related to Hemobilia after Percutaneous Liver Biopsy

Coşkun¹,

Sezgin²,

Kahraman³

2017

Erciyes Med J

View full text Add to dashboard Cite

Percutaneous liver biopsy is a reliable method used for the diagnosis and follow-up of many liver diseases. Although it is safe, major complications, such as free intraperitoneal bleeding, hemothorax, pneumothorax, hemobilia, and Pseudoaneurysm, have rarely been reported to be related to the procedure. The reported rate of hemobilia after performing percutaneous liver biopsy is approximately 0.06%. This event usually results from a hepatic artery pseudoaneurysm and can potentially cause fatal bleeding. In addition, acute cholecystitis and pancreatitis are rare complications of hemobilia. To the best of our knowledge, we report the third case of a patient who developed hemobilia, acute cholecystitis, and acute pancreatitis from a pseudoaneurysm after performing percutaneous liver biopsy. The bleeding was successfully controlled by angiographic embolization with glue and lipidiol.

show abstract

Acute Pancreatitis and Acute Cholecystitis Caused by Hemobilia after Percutaneous Ultrasound-Guided Liver Biopsy

Cited by 18 publications

References 1 publication

Hyaluronic acid in the evaluation of liver fibrosis in patients with hepatitis C on haemodialysis

Hyaluronic acid in the evaluation of liver fibrosis in patients with hepatitis C on haemodialysis

Acute pancreatitis secondary to hemobilia after percutaneous liver biopsy

Acute Cholecystitis and Acute Pancreatitis related to Hemobilia after Percutaneous Liver Biopsy

Contact Info

Product

Resources

About